Patent · US Active

Composition and method for preparing plasminogen

US8268782B2 · kind B2 · utility

5Cited by
47References
15Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 6, 2009
Grant dateSep 18, 2012
Priority date
Expiry dateMar 6, 2029

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K47/26
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Disclosed is both a method for preparing a plasminogen and a method for preparing a reversibly inactive acidified plasmin by activating the plasminogen. The prepared plasminogen is typically purified from a fraction obtained in the separation of immunoglobulin from Fraction II+III chromatographic process and eluted at a low pH. The prepared plasmin is isolated and stored with a low pH-buffering capacity agent to provide a substantially stable formulation. The reversibly inactive acidified plasmin may be used in the administration of a thrombolytic therapy.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.